Solid dispersions, Part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs

Bibliography

• Amidon GL, Lennernas H, Shah VP, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-20
   PubMed Web of Science ®Google Scholar
• Lipinski C. Poor aqueous solubility–an industry wide problem in drug delivery. Am Pharm Rev 2002;5:82-5
   Google Scholar
• Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001;46:75-87
   PubMed Web of Science ®Google Scholar
• Mosharraf M, Nystrom C. The effect of dry mixing on the apparent solubility of hydrophobic, sparingly soluble drugs. Eur J Pharm Sci 1999;9:145-56
   PubMed Web of Science ®Google Scholar
• Stegemann S, Leveiller F, Franchi D, When poor solubility becomes an issue: from early stage to proof of concept. Eur J Pharm Sci 2007;31:249-61
   PubMed Web of Science ®Google Scholar
• Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281-302
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068-75
   PubMed Web of Science ®Google Scholar
• Kesisoglu F, Panmai S, Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007;59:631-44
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water soluble compounds. Eur J Pharm Sci 2003;18:113-20
   PubMed Web of Science ®Google Scholar
• Cho E, Cho W, Cha KH, Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives. Int J Pharm 2010;396:91-8
   PubMed Web of Science ®Google Scholar
• Hancock BC, Parks M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res 2000;17:397-404
   PubMed Web of Science ®Google Scholar
• Janssens S, Van den Mooter G. Review: physical chemistry of solid dispersions. J Pharm Pharmacol 2009;61:1571-86
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47-60
   PubMed Web of Science ®Google Scholar
• Craig DQM. The mechanisms of drug release from solid dispersions in water soluble polymers. Int J Pharm 2002;231:131-44
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058-66
   PubMed Web of Science ®Google Scholar
• Talegaonkar S, Azeem A, Ahmad FJ, Microemulsions: a novel approach to enhanced drug delivery. Recent Pat Drug Deliv Formul 2008;2:238-57
   PubMedGoogle Scholar
• Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59:645-66
   PubMed Web of Science ®Google Scholar
• Rahman Z, Zidan AS, Khan MA. Formulation and evaluation of a protein-loaded solid dispersions by non-destructive methods. AAPS J 2010;12:158-70
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun C, Hao Y, Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. J Pharm Pharm Sci 2010;13:589-606
   PubMed Web of Science ®Google Scholar
• Peltonen L, Valo H, Kolakovic R, Electrospraying, spray drying and related techniques for production and formulation of drug nanoparticles. Expert Opin Drug Deliv 2010;7:705-19
   PubMed Web of Science ®Google Scholar
• Crowley MM, Zhang F, Repka MA, Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 2007;33:909-26
   PubMed Web of Science ®Google Scholar
• Bikiaris D, Papageorgiou GZ, Stergiou A, Physicochemical studies on solid dispersions of poorly water-soluble drugs. Evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta 2005;439:58-67
   Web of Science ®Google Scholar
• Karavas E, Georgarakis E, Sigalas MP, Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug–polymer interactions. Eur J Pharm Biopharm 2007;66:334-47
   PubMed Web of Science ®Google Scholar
• Kanaze FI, Kokkalou E, Niopas I, Dissolution enhancement of flavonoids by solid dispersion in PVP and PEG matrixes: a comparative study. J Appl Polym Sci 2006;102:460-71
   Web of Science ®Google Scholar
• Kanaze FI, Kokkalou E, Niopas I, Thermal analysis study of flavanoid solid dispersions having enhanced solubility. J Therm Anal Cal 2006;83:283-90
   Web of Science ®Google Scholar
• Al-Hamidi H, Edwards AA, Mohammad MA, To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf B Biointerfaces 2010;76:170-8
   PubMed Web of Science ®Google Scholar
• Biswal S, Sahoo J, Murthy PN, Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmSciTech 2008;9:563-70
   PubMed Web of Science ®Google Scholar
• Kanaze FI, Kokkalou E, Niopas I, Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions. Drug Dev Ind Pharm 2010;36:292-301
   PubMed Web of Science ®Google Scholar
• Karavas E, Georgarakis E, Bikiaris D. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int J Pharm 2006;313:189-97
   PubMed Web of Science ®Google Scholar
• Karavas E, Georgarakis M, Docoslis A, Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix. Int J Pharm 2007;340:76-83
   PubMed Web of Science ®Google Scholar
• Papageorgiou GZ, Docoslis A, Georgarakis M, The effect of physical state on the drug dissolution rate. Miscibility studies of nimodipine with PVP. J Therm Anal Cal 2009;95:903-15
   Web of Science ®Google Scholar
• Muela S, Escalera B, Pena MA, Bustamante P. Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and co-solvents. Int J Pharm 2010;384:93-9
   PubMed Web of Science ®Google Scholar
• Pandya P, Gattani S, Jain P, Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro–in vivo evaluation. AAPS PharmSciTech 2008;9:1247-52
   PubMed Web of Science ®Google Scholar
• Joe JH, Lee WM, Park YJ, Effect of the solid-dispersion method on the solubility and crystalline property of Tacrolimus. Int J Pharm 2010;395:161-6
   PubMed Web of Science ®Google Scholar
• Planinsek O, Kovacic B, Vrecer F. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica. Int J Pharm 2011;406:41-8
   PubMed Web of Science ®Google Scholar
• Wang F, Hui H, Barnes TJ, Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Mol Pharm 2010;7:227-36
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang T, Zhang Q, Inclusion of telmisartan in MCF nanoparticles: drug loading and release property. Eur J Pharm Biopharm 2010;76:17-23
   PubMed Web of Science ®Google Scholar
• Sinha S, Ali M, Baboota S, Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech 2010;11:518-27
   PubMed Web of Science ®Google Scholar
• Li DX, Jang KY, Kang WK, Enhanced solubility and bioavailability of sibutramine base by solid dispersion system with aqueous medium. Biol Pharm Bull 2010;33:279-84
   PubMed Web of Science ®Google Scholar
• Ghareeb MM, Abdulrasool AA, Hussein AA, Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. AAPS PharmSciTech 2009;10:1206-15
   PubMed Web of Science ®Google Scholar
• Chaulang G, Patel P, Hardikar S, Formulation and evaluation of solid dispersions of furosemide in sodium starch glycolate. Trop J Pharm Res 2009;8:43-51
   Web of Science ®Google Scholar
• Maulvi FA, Dalwadi SJ, Thakkar VT, Improvement of dissolution rate of aceclofenac by solid dispersion technique. Powder Technol 2011;207:47-54
   Web of Science ®Google Scholar
• Patel HM, Suhagia BN, Shah SA, Preparation and characterization of etoricoxib-beta-cyclodextrin complexes prepared by the kneading method. Acta Pharm 2007;57:351-9
   PubMedGoogle Scholar
• Sapkal NP, Kilor VA, Bhusari KP, Evaluation of some methods for preparing gliclazide-beta-Cyclodextrin inclusion complexes. Trop J Pharm Res 2007;6:833-40
   Web of Science ®Google Scholar
• Fernandes CM, Vieira MT, Veiga FJB. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur J Pharm Sci 2002;15:79-88
   PubMed Web of Science ®Google Scholar
• Figueiras A, Carvalho RA, Ribeiro L, Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. Eur J Pharm Biopharm 2007;67:531-9
   PubMed Web of Science ®Google Scholar
• Dua K, Ramana MV, Sara UVS, Investigation of enhancement of solubility of norfloxacin beta-cyclodextrin in presence of acidic solubilizing additives. Curr Drug Deliv 2007;4:21-5
   PubMedGoogle Scholar
• Sonali D, Tejal S, Vaishali T, Silymarin-solid dispersions: Characterization and influence of preparation methods on dissolution. Acta Pharm 2010;60:427-43
   PubMed Web of Science ®Google Scholar
• Rasenack N, Muller BW. Micron-size drug particles: common and novel micronization techniques. Pharm Dev Technol 2004;9:1-13
   PubMed Web of Science ®Google Scholar
• Hu J, Johnston KP, Williams RO III. Nanoparticle engineering processes for enhancing the dissolution rates. Drug Dev Ind Pharm 2004;30:233-45
   PubMed Web of Science ®Google Scholar
• Niwa T, Hashimoto N. Novel technology to prepare oral formulations for preclinical safety studies. Int J Pharm 2008;350:70-8
   PubMedGoogle Scholar
• Merisko-Liversidge E, McGurk SL, Liversidge GG. Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin. Pharm Res 2004;21:1545-51
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Inkyo M, Yumoto R, Nanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders. Chem Pharm Bull (Tokyo) 2009;57:1050-7
   PubMed Web of Science ®Google Scholar
• Yang W, Johnston KP, Williams RO III. Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats. Eur J Pharm Biopharm 2010;75:33-41
   PubMed Web of Science ®Google Scholar
• Onoue S, Aoki Y, Matsui T, Development of inhalable nanocrystalline solid dispersion of tranilast for airway inflammatory diseases. J Pharm Sci 2011;100:622-33
   PubMed Web of Science ®Google Scholar
• Onoue S, Sato H, Ogawa K, Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach. Int J Pharm 2010;399:94-101
   PubMed Web of Science ®Google Scholar
• Li N, DeGennaro MD, Liebenberg W, Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process. Pharmazie 2006;61:595-603
   PubMed Web of Science ®Google Scholar
• Jinno J, Kamada N, Miyake M, In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. J Control Release 2008;130:29-37
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Pillai R, Venkateshwarlu V, Development and characterization of solid oral dosage form incorporating candesartan nanoparticles. Pharm Dev Technol 2009;14:290-8
   PubMed Web of Science ®Google Scholar
• Dai WG, Dong LC, Song YQ. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate. Int J Pharm 2007;342:201-7
   PubMed Web of Science ®Google Scholar
• Araujo RR, Teixeira CCC, Freitas LAP. The preparation of ternary solid dispersions of an herbal drug via spray drying of liquid feed. Drying Technol 2010;28:412-21
   Web of Science ®Google Scholar
• Janssens S, Anne M, Rombaut P, Spray drying from complex solvent systems broadens the applicability of Kollicoat IR as a carrier in the formulation of solid dispersions. Eur J Pharm Sci 2009;37:241-8
   PubMed Web of Science ®Google Scholar
• Sansone F, Picerno P, Mencherini T, Flavonoid microparticles by spray-drying: influence of enhancers of the dissolution rate on properties and stability. J Food Eng 2011;103:188-96
   Web of Science ®Google Scholar
• Kondo M, Niwa T, Okamoto H, Particle characterization of poorly water-soluble drugs using a spray freeze drying technique. Chem Pharm Bull (Tokyo) 2009;57:657-62
   PubMed Web of Science ®Google Scholar
• Al-Obaidi H, Brocchini S, Buckton G. Anomalous properties of spray dried solid dispersions. J Pharm Sci 2009;98:4724-37
   PubMed Web of Science ®Google Scholar
• Gao Y, Qian S, Zhang J. Physicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension. Chem Pharm Bull (Tokyo) 2010;58:912-17
   PubMed Web of Science ®Google Scholar
• Uchiyama H, Tozuka Y, Imono M, Improvement of dissolution and absorption properties of poorly water-soluble drug by preparing spray-dried powders with alpha-glucosyl hesperidin. Int J Pharm 2010;392:101-6
   PubMedGoogle Scholar
• Wu K, Li J, Wang W, Winstead DA. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent. J Pharm Sci 2009;98:2422-31
   PubMed Web of Science ®Google Scholar
• Tong HHY, Du Z, Wang GN, Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound. Int J Pharm 2011;404:148-58
   PubMed Web of Science ®Google Scholar
• Wang L, Cui FD, Sunada H. Improvement of the dissolution rate of nitrendipine using a new pulse combustion drying method. Chem Pharm Bull (Tokyo) 2007;55:1119-25
   PubMed Web of Science ®Google Scholar
• Sahoo NG, Kakran M, Li L, Dissolution enhancement of a poorly water-soluble antimalarial drug by means of a modified multi-fluid nozzle pilot spray drier. Matter Sci Eng C 2011;31:391-9
   Web of Science ®Google Scholar
• Rogers TL, Nelsen AC, Hu J, A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur J Pharm Biopharm 2002;54:271-80
   PubMed Web of Science ®Google Scholar
• Patel SG, Rajput SJ. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. AAPS PharmSciTech 2009;10:660-9
   PubMed Web of Science ®Google Scholar
• Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release 2007;123:78-99
   PubMed Web of Science ®Google Scholar
• Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: Past, present and future. Nat Rev Drug Discov 2004;3:1023-35
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME, Masson M. Role of cyclodextrins in improving oral drug delivery. Am J Drug Deliv 2004;2:261-75
   Google Scholar
• Gamsiz ED, Miller L, Thombre AG, Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development. Biotechnol Bioeng 2010;105:409-20
   PubMed Web of Science ®Google Scholar
• Tao T, Zhao Y, Wu J, Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement. Int J Pharm 2009;367:109-14
   PubMed Web of Science ®Google Scholar
• Makhlof A, Miyazaki Y, Tozuka Y, Cyclodextrins as stabilizers for the preparation of drug nanocrystals by the emulsion solvent diffusion method. Int J Pharm 2008;357:280-5
   PubMed Web of Science ®Google Scholar
• Hassan HA, Al-Marzouqi AH, Jobe B, Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide. J Pharm Biomed Anal 2007;45:243-50
   PubMed Web of Science ®Google Scholar
• Challa R, Ahuja A, Ali J, Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech 2005;6:E329-57
   PubMed Web of Science ®Google Scholar
• Mady FM, Abou-Taleb AE, Khaled KA, Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CD/povidone K30 complexation approach. J Pharm Sci 2010;99:4285-94
   PubMed Web of Science ®Google Scholar
• Yadav VR, Suresh S, Devi K, Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AAPS PharmSciTech 2009;10:752-62
   PubMed Web of Science ®Google Scholar
• Yoshida A, Yamamoto M, Itoh T, Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine. Chem Pharm Bull (Tokyo) 1990;38:176-9
   PubMed Web of Science ®Google Scholar
• Hirayama F, Usami M, Kimura K, Crystallization and polymorphic transition behavior of chloramphenicol palmitate in 2-hydroxypropyl-beta-cyclodextrin matrix. Eur J Pharm Sci 1997;5:23-30
   Web of Science ®Google Scholar
• Yano H, Kleinebudde P. Improvement of dissolution behavior for poorly water-soluble drug by application of cyclodextrin in extrusion process: Comparison between melt extrusion and wet extrusion. AAPS PharmSciTech 2010;11:885-93
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Gonzalez-Rodriguez ML, Rabasco AM, New “drug-in cyclodextrin-in deformable liposomes” formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm 2010;395:222-3
   PubMed Web of Science ®Google Scholar
• Bikiaris D. Solid dispersions, Part II: new strategies in manufacturing methods for dissolution rate enhancement of poorly water soluble drugs. Expert Opin Drug Deliv Sep 2011. [Epub ahead of print]
   Web of Science ®Google Scholar
• Pajula K, Taskinen M, Lehto VP, Predicting the formation and Stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram. Mol Pharm 2010;7:795-04
   PubMed Web of Science ®Google Scholar
• Paudel A, Van Humbeeck J, Van den Mooter G. Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone). Mol Pharm 2010;7:1133-48
   PubMed Web of Science ®Google Scholar
• Caron V, Bhugra C, Pikal MJ. Prediction of onset of crystallization in amorphous pharmaceutical systems: Phenobarbital, nifedipine/PVP, and phenobarbital/PVP. J Pharm Sci 2010;99:3887-00
   PubMed Web of Science ®Google Scholar